Safety and efficacy of BI 695501 versus adalimumab reference product in patients with advanced Crohn's disease (VOLTAIRE-CD): a multicentre, randomised, double-blind, phase 3 trial

The Lancet Gastroenterology & Hepatology - Tập 6 - Trang 816-825 - 2021
Stephen Hanauer1, Bernd Liedert2, Sigrid Balser3, Ekkehard Brockstedt4, Viktoria Moschetti4, Stefan Schreiber5
1Feinberg School of Medicine, Northwestern University, Chicago, IL, USA
2Sandoz Biopharmaceuticals, Holzkirchen, Germany
3Boehringer Ingelheim Pharma, Biberach an der Riss, Germany
4Boehringer Ingelheim Pharma, Ingelheim am Rhein, Germany
5Klinik für Innere Medizin I, Universitaetsklinikum Schleswig-Holstein, Kiel University, Kiel, Germany

Tài liệu tham khảo

Thông tin
Thông tin xuất bản

The Lancet Gastroenterology & Hepatology

Tập 6

816-825

Thông tin tác giả